IndraLab

Statements


| 2

reach
"By inhibiting miR-155 expression progesterone can down-regulate both MyD88 and TRIF dependent signaling pathways as well as IL-6 and IFN-beta production."

reach
"Estrogen and progesterone appear to inhibit MyD88, thereby illustrating how clinical and tumor related factors - chemotherapy, MyD88, and estrogen and progesterone - might together plausibly give rise to interactions that modify clinical outcomes."